PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Biomedical Sciences & Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.\', \'Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.\', \'University of South Australia, Adelaide, South Australia, Australia.\', \'VP System Practice, International Society for the System Sciences, Pontypool, UK.\', \'Florey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, Victoria, Australia.\', \'Centre for Drug Repurposing and Medicines Research, Clinical Pharmacology, University of Newcastle, Newcastle, New South Wales, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/prp2.917
?:hasPublicationType
?:journal
  • Pharmacology research & perspectives
is ?:pmid of
?:pmid
?:pmid
  • 35106954
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all